China stimulus spurs healthy mean reversion in Asia: Manishi Raychaudhuri
Repeats, text unchanged. The views expressed here are those of the author, chief executive officer of Emmer Capital Partners Ltd.
By Manishi Raychaudhuri
Nov 21 -It’s still unclear whether the Chinese government’s efforts to revive the country’s ailing economy will prove successful, but the stimulus measures already appear to be having one positive side effect: valuations in most Asian equity markets have shifted into healthier territory.
Beijing began to roll out a raft of monetary and fiscal stimulus measures in late September, including debt swaps with local governments, cuts to borrowing rates, measures to facilitate property purchases and policies to promote corporate buybacks.
While the actions designed to support the property market have yet to bear fruit, those aimed at boosting China’s equity market had an immediate impact. China’s CSI 300 index spiked by more than 30% in a little over two weeks after the announcement of enhanced stimulus measures.
At roughly the same time, many other Asian equity markets experienced massive outflows. In October, an unprecedented $15 billion of foreign institutional money flew out of non-China Asian equity markets, with India and Korea accounting for more than 95%.
This has caused Asian equity market valuations, which were quite divergent until recently, to begin reverting to the mean.
MEAN REVERSION
This trend is best illustrated by viewing Asian equity market valuations against the countries’ respective growth forecasts.
Based on this comparison, almost all countries have moved closer to the regional trend line. Indonesian equities have turned slightly cheaper since mid-August, while Thailand has become a little more expensive. And, most notably, China’s relative position has shifted from undervalued to in line with expectations.
India, the priciest market before the correction with a price-to-earnings ratio of 26x, experienced the most dramatic decline. The country’s equity index, the Nifty 50, fell by 8.5% from the September 26 peak through the end of October.
While India’s equity multiple has not decreased significantly, it has moved much closer to the trend line for the region. That’s because the “re-rating” of China’s market has pushed up the average PE multiple for the region.
HEALTHY CORRECTION
This mean reversion is healthy for two key reasons.
First, valuations are becoming more closely aligned with fundamentals. Chinese equities, which were arguably under-owned before September, reacted significantly to a meaningful positive catalyst. That’s exactly how markets are supposed to function.
Second, fundamentally attractive but expensive markets, such as India, saw their premiums slashed. This should help these countries attract more foreign investors, who have become increasingly wary of investing in emerging markets at extremely high multiples.
Consider the relative equity valuations in China and India. Both markets traded at premium valuations relative to the Asia ex-Japan average over the past 15 years: China at 20% and India at 25%.
One could reasonably argue that India deserves to trade at a premium to its Asian peers: it’s the fastest growing Group of 20 economy, has a large liquid market with a broad range of growing sectors, and has many companies that consistently generate returns in excess of their cost of equity.
The question is, how much to pay for this market? Before the correction in October, India was trading at a premium near 90%. A figure that large likely made many foreign investors cautious.
But the relative premium has since fallen below 60%. That’s still on the high side, but the drop may be big enough to make more foreign investors give India another look.
This is a classic healthy correction: the divergence between valuation and fundamentals is diminishing.
CAVEAT EMPTOR
Of course, capital flows and relative valuations are not the only drivers of investment decisions. Robust earnings and return on capital are more vital over the long term. And most Asian equity markets have seen average earnings estimates decline since the summer of 2024 – some for much longer.
So even though Asian equity valuations may be more in line with the long-term regional average, careful sector and market selection is still warranted.
It also remains to be seen whether the recent correction will prove durable. The Chinese equity rally has fizzled over the past month, likely because investors believe more direct fiscal stimulus is needed to boost consumption in the country.
If Beijing responds with more stimulative firepower, the initial beneficiaries may be investors seeking to find value across the region.
Foreign institutional equity flows into Asia excl. China and Japan ($US mm) https://www.reuters.com/graphics/ASIA-STOCKS/jnvwjjmqzpw/chart.png
Forecast EPS growth and PE Multiples for Asia ex Japan: Mid-August 2024 https://www.reuters.com/graphics/ASIA-STOCKS/byprmmggyve/chart.png
Forecast EPS growth and PE multiples for Asia ex Japan: Early November 2024 https://www.reuters.com/graphics/ASIA-STOCKS/jnpwjjmmzvw/chart.png
Chinese equities are still trading at a discount to the long-term average https://www.reuters.com/graphics/ASIA-STOCKS/gdvzkkxzapw/chart.png
Indian equities are still trading at a significant premium https://www.reuters.com/graphics/ASIA-STOCKS/zjvqnnrxepx/chart.png
Writing by Manishi Raychaudhuri; editing by Anna Szymanski and Andrew Heavens
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
